pKa Buffered Vitamin C Composition and Method

Abstract

A pKa buffered vitamin C composition which includes a base alkalizer composition mixed with vitamin C (calcium ascorbate or ascorbic acid). The base alkalizer composition can be approximately 24% to 40% and the ascorbic acid or calcium ascorbate can be approximately 76% to 60% by weight of the vitamin C composition. When this vitamin C composition is orally administered to an individual (in capsule or tablet form), a rapid neutralization of his stomach acid occurs followed by a sustained pH of 6.0 to 7.5 for a thirty minute to two hour period. This allows the ingredients to be absorbed in his stomach, while preventing unpleasant reactions in his stomach. The base alkalizer composition can include the combination of a calcium carbonate carrier which acts as a mild alkalizer, an hydroxide (magnesium or potassium) which acts as a fast alkalizer, and a phosphate (dicalcium or tricalcium) which acts as a moderate alkalizer and which also maintains the pH fairly stable over a twenty to forty minute time period.

What is claimed is: 
     
         1 . A pKa buffered vitamin C composition, comprising:
 an alkalizing base composition consisting essentially of calcium carbonate, magnesium hydroxide, directly compressible (DC) ascorbic acid, potassium hydroxide, gum acacia and dicalcium phosphate; and   a vitamin C source mixed with the alkalizing base composition.   
     
     
         2 . The pKa buffered vitamin C composition of  claim 1  wherein the pKa buffered vitamin C composition comprises from about 24% to about 40% by weight of the base composition and from about 76% to about 60% by weight of the vitamin C source. 
     
     
         3 . The pKa buffered vitamin C composition of  claim 1  wherein the base composition consists essentially of by % weight from about 70 to about 85 of the calcium carbonate, from about 5 to about 8 of the magnesium hydroxide, from about 0.01 to about 6 of the DC ascorbic acid, from about 0.01 to about 6 of the potassium hydroxide, from about 0.01 to about 6 of the dicalcium phosphate, and from about 0.01 to about 6 of gum acacia. 
     
     
         4 . The pKa buffered vitamin C composition of  claim 1  wherein the vitamin C source is calcium ascorbate or ascorbic acid and is dry blended in powder or granular form with the alkalizing base composition. 
     
     
         5 . A pKa buffered vitamin C composition, comprising:
 an alkalizing base composition consisting essentially of calcium carbonate, potassium hydroxide, potassium bicarbonate, dicalcium phosphate, gum acacia and tricalcium phosphate;   and a vitamin C source mixed with the alkalizing base composition.   
     
     
         6 . The pKa buffered vitamin C composition of  claim 5  wherein the pKa buffered vitamin C composition comprises from about 24% to about 40% by weight of the base composition and from about 76% to about 60% by weight of the vitamin C source. 
     
     
         7 . The pKa buffered vitamin C composition of  claim 5  wherein the alkalizing base composition consists essentially of by % weight from about 75 to about 90 of the calcium carbonate, from about 0.01 to about 6 of the potassium hydroxide, from about 4 to about 10 of the potassium bicarbonate, from about 0.01 to about 4 of the dicalcium phosphate, from about 0.01 to about 4 of the tricalcium phosphate, and from about 1.0 to about 5 of gum acacia. 
     
     
         8 . The pKa buffered vitamin C composition of  claim 5  wherein the vitamin C source is calcium ascorbate or ascorbic acid and is dry blended in powder or granular form with the alkalizing base composition. 
     
     
         9 . A pKa buffered vitamin C composition, comprising:
 an alkalizing base composition consisting of calcium carbonate, potassium hydroxide, potassium carbonate, gum acacia and dicalcium phosphate; and   a vitamin C source mixed with the alkalizing base composition.   
     
     
         10 . The pKa buffered vitamin C composition of  claim 9  wherein the pKa buffered vitamin C composition comprises from about 24% to about 40% by weight of the alkalizing base composition and from about 76% to about 60% by weight of the vitamin C source. 
     
     
         11 . The pKa buffered vitamin C composition of  claim 9  wherein the vitamin C source is calcium ascorbate or ascorbic acid and is dry blended in powder or granular form with the alkalizing base composition. 
     
     
         12 . The pKa buffered vitamin C composition of  claim 9  wherein the alkalizing base composition consists essentially of by % weight from about 70 to about 90 of the calcium carbonate, from about 4 to about 7 of the potassium hydroxide, from about 0.01 to about 6 of the potassium carbonate, and from 0.01 to about 3 of the dicalcium phosphate. 
     
     
         13 . A pKa buffered vitamin C composition, comprising:
 a base alkalizer composition which consists essentially of calcium carbonate, an hydroxide and a phosphate;   a vitamin C source mixed with the base alkalizer composition; and   the base alkalizer being approximately 24% to 40% by weight and the vitamin C source being approximately 76% to 60% by weight.   
     
     
         14 . The pKa buffered vitamin C composition of  claim 13  wherein the vitamin C source is calcium ascorbate or ascorbic acid blended with the base alkalizer composition. 
     
     
         15 . A method of administering vitamin C to a human, comprising:
 providing a pKa buffered vitamin C composition in a dietary supplement form; and   causing the human to orally ingest the pKa buffered vitamin C composition such that the vitamin C composition causes a rapid neutralization of the human's stomach acid followed by a sustained pH of approximately 6.0 to 7.5 for approximately a thirty minute to two hour period.   
     
     
         16 . The method of  claim 15  wherein the pKa buffered vitamin C composition includes a base alkalizer composition, and a vitamin C source mixed with the base alkalizer composition; the base alkalizer being approximately 24% to 40% by weight and the vitamin C source being approximately 76% to 60% by weight; and the base alkalizer composition including calcium carbonate, an hydroxide and a phosphate. 
     
     
         17 . The method of  claim 15  wherein the dietary supplement form is one or more capsules, tablets or pills. 
     
     
         18 . A pKa buffered vitamin C composition, consisting of :
 an alkalizing base composition including calcium carbonate, magnesium hydroxide, directly compressible (DC) ascorbic acid, a binder, potassium hydroxide and dicalcium phosphate; and   a vitamin C source mixed with the alkalizing base composition.   
     
     
         19 . A pKa buffered vitamin C composition, consisting of:
 an alkalizing base composition including calcium carbonate, potassium hydroxide, a binder, potassium bicarbonate, dicalcium phosphate and tricalcium phosphate; and   a vitamin C source mixed with the alkalizing base composition.   
     
     
         20 . A pKa buffered vitamin C composition, consisting of:
 an alkalizing base composition including calcium carbonate, potassium hydroxide, potassium carbonate and dicalcium phosphate; and   a vitamin C source mixed with the alkalizing base composition.   
     
     
         21 . An alkalizing composition base composition consisting essentially of calcium carbonate, magnesium hydroxide, potassium hydroxide and dicalcium phosphate. 
     
     
         22 . An alkalizing composition base composition of  claim 21  further comprising potassium bicarbonate. 
     
     
         23 . An alkalizing composition base composition of  claim 21  wherein the % by weight of magnesium hydroxide is from about 5% to about 20% of the % by weight of calcium carbonate;
 the % by weight of potassium hydroxide is from about 1% to about 5% of the % by weight of calcium carbonate; and the % by weight of dicalcium phosphate is from about 0.5% to about 5% of the % by weight of calcium carbonate. 
 
     
     
         24 . An alkalizing composition base composition of  claim 21  wherein the % by weight of magnesium hydroxide is from about 7.5% to about 15% of the % by weight of calcium carbonate;
 the % by weight of potassium hydroxide is from about 1.5% to about 3% of the % by weight of calcium carbonate; and the % by weight of dicalcium phosphate is from about 1.2% to about 3% of the % by weight of calcium carbonate. 
 
     
     
         25 . An alkalizing composition base composition of  claim 21  wherein the % by weight of magnesium hydroxide is from about 8.5% to about 12% of the % by weight of calcium carbonate;
 the % by weight of potassium hydroxide is from about 2% to about 2.8% of the % by weight of calcium carbonate; and the % by weight of dicalcium phosphate is from about 1.4% to about 2.6% of the % by weight of calcium carbonate.